Earnings History Data for Vaxart, Inc. (VXRT) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Vaxart, Inc.
Vaxart, Inc. is a clinical-stage company developing a range of oral recombinant vaccines based on its proprietary delivery platform. The company's vaccines are administered using convenient room temperature-stable tablets that can be stored and shipped without refrigeration and eliminate risk of needle-stick injury. Its development programs are oral tablet vaccines designed to protect against norovirus, seasonal influenza and respiratory syncytial virus, as well as a therapeutic vaccine for human papillomavirus. Vaxart, Inc., formerly known as Aviragen Therapeutics, is based in South San Francisco, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13-11-2024 | AH | VXRT | Vaxart, Inc. | 157.80 | -0.06 | -0.10 | -0.11 | Vaxart GAAP EPS of -$0.06 beats by $0.04, revenue of $4.93M beats by $3.43M [11/13/2024 4:03 PM] |
0.6307 | -0.08 (-11.70%) |
0.69 | -0.02 (-2.70%) |
0.52 - 1.54 | 2,435,423 | 1,410,000 | 15,110 | ||
| 08-08-2024 | AH | VXRT | Vaxart, Inc. | 107.45 | -0.09 | 0.03 | -0.16 | Vaxart GAAP EPS of -$0.09 misses by $0.06, revenue of $6.4M misses by $15.57M [8/8/2024 4:02 PM] |
0.5817 | -0.05 (-7.68%) |
0.62 | -0.01 (-1.60%) |
0.52 - 1.54 | 1,824,682 | 1,550,000 | 20,898 | ||
| 13-05-2024 | AH | VXRT | Vaxart, Inc. | 127.20 | -0.14 | -0.16 | -0.19 | Vaxart GAAP EPS of -$0.14 in-line, revenue of $2.18M beats by $1.38M [5/13/2024 4:03 PM] |
0.8690 | 0.05 (5.98%) |
0.90 | 0.08 (10.28%) |
0.53 - 1.59 | 2,105,007 | 1,410,000 | 178,945 | ||
| 14-03-2024 | AH | VXRT | Vaxart, Inc. | 173.32 | -0.12 | -0.14 | -0.18 | Vaxart GAAP EPS of -$0.57 beats by $0.02, revenue of $7.4M beats by $2.19M [3/14/2024 4:15 PM] |
1.10 | 0.0 (0.00%) |
1.10 | 0.0 (0.00%) |
0.53 - 1.59 | 1,540,686 | 1,390,000 | 3,263 | ||
| 02-11-2023 | AH | VXRT | Vaxart, Inc. | 100.39 | -0.11 | -0.18 | -0.23 | Vaxart GAAP EPS of -$0.11 beats by $0.07, revenue of $2.1M beats by $2M [11/2/2023 4:09 PM] |
0.70 | 0.03 (5.09%) |
0.67 | 0.0 (0.42%) |
0.56 - 1.73 | 1,146,452 | 730,000 | 20,544 | ||
| 03-08-2023 | AH | VXRT | Vaxart, Inc. | 105.73 | -0.16 | -0.19 | -0.23 | Vaxart GAAP EPS of -$0.16 beats by $0.02, revenue of $1.36M beats by $1.28M [8/3/2023 4:06 PM] |
0.7615 | 0.01 (1.53%) |
0.79 | 0.04 (5.20%) |
0.56 - 4.61 | 692,366 | 910,000 | 2,390 | ||
| 04-05-2023 | AH | 4:00 PM ET (May 4) |
VXRT | Vaxart, Inc. | 112.04 | -0.19 | -0.19 | -0.20 | Vaxart GAAP EPS of -$0.19 in-line, revenue of $0.67M misses by $0.13M [5/4/2023 4:27 PM] |
0.8681 | 0.01 (0.94%) |
0.82 | -0.04 (-4.65%) |
0.56 - 4.61 | 590,108 | 880,000 | 21,845 | |
| 15-03-2023 | AH | 4:00 PM ET (Mar 15) |
VXRT | Vaxart, Inc. | 120.11 | -0.18 | -0.22 | -0.17 | Vaxart GAAP EPS of -$0.84 misses by $0.01 [3/15/2023 4:02 PM] |
0.7838 | 0.02 (3.12%) |
0.73 | -0.03 (-3.30%) |
0.73 - 5.43 | 974,593 | 1,740,000 | 12,062 | |
| 08-11-2022 | AH | 4:00 PM ET (Nov 8) |
VXRT | Vaxart, Inc. | 187.23 | -0.23 | -0.24 | -0.14 | Vaxart GAAP EPS of -$0.23 beats by $0.01 [11/8/2022 4:03 PM] |
1.26 | -0.12 (-8.99%) |
1.41 | 0.02 (1.55%) |
1.26 - 8.13 | 3,563,785 | 3,000,000 | 10,922 | |
| 08-08-2022 | AH | 5:45 PM ET (Aug 8) |
VXRT | Vaxart, Inc. | 472.91 | -0.23 | -0.21 | -0.13 | Vaxart GAAP EPS of -$0.23, revenue of $0M [8/8/2022 4:21 PM] |
4.22 | -0.07 (-1.63%) |
3.93 | -0.36 (-8.39%) |
2.49 - 10.33 | 2,972,417 | 2,450,000 | 46,480 | |
| 04-11-2021 | AH | VXRT | VAXART | 903.00 | -0.14 | -0.15 | 0.00 | Vaxart EPS in-line, beats on revenue [11/4/2021 5:22 PM] |
6.69 | -0.20 (-2.90%) |
6.79 | -0.10 (-1.45%) |
3.50 - 24.90 | 5,034,077 | 3,120,000 | 182,371 | ||
|
||||||||||||||||||
| 03-05-2021 | PM | VXRT | Vaxart, Inc. | 1,085 | -0.14 | -0.10 | 0.00 | Vaxart EPS misses by $0.04, misses on revenue [5/3/2021 8:19 AM] |
8.01 | -2.77 (-25.70%) |
9.96 | -0.82 (-7.61%) |
2.23 - 24.90 | 77,370,949 | 53,570,000 | 12,045,385 | ||
|
||||||||||||||||||
| 12-05-2020 | AH | VXRT | Vaxart, Inc. | 211.12 | -0.02 | -0.04 | -0.18 | Vaxart EPS beats by $0.02, beats on revenue [5/12/2020 4:25 PM] |
2.79 | -0.22 (-7.31%) |
2.85 | 0.06 (2.15%) |
0.25 - 4.12 | 6,224,280 | 5,742,627 | 59,889 | ||
|
|
||||||||||||||||||